Deep, focused upcoming-generation sequencing has discovered that subclonal mutations (i.e., those current in just a portion of tumor cells) may be detected for all driver genes and so are associated with swift disease progression and lousy outcome.11–thirteen This is especially applicable for TP53 mutations provided The point that, as discussed https://amirx985xfm2.blogproducer.com/profile